Modular Medical, Inc.
MODDNasdaq
$2.98
↓ -8.0%Jul 17 close · end-of-day
Price
1Y↓ -85.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$6.8M
Enterprise Value
-$132,700.00
P/E
—
P/S
—
P/B
0.5
EV/EBITDA
—
PEG
—
FCF Yield
-406.6%
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$28.2M
Free Cash Flow (TTM)
-$27.7M
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-217.9%
ROIC
-361.9%
Debt / Equity
—
Net Cash
$6.9M
Return 1Y
-85.7%
Company profile
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps. The company is headquartered in San Diego, California.
- CEO
- James E. Besser
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 20
- Headquarters
- California
- Website
- modular-medical.com
Earnings
MODD Q4 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$11.99↓ -19.4%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$7.3M | -$14.9M | -$13.9M | -$17.5M | -$19.0M | -$27.6M |
| Net income | -$7.4M | -$18.6M | -$13.9M | -$17.5M | -$18.8M | -$28.2M |
| Diluted EPS | — | -$2.74 | -$1.15 | -$0.78 | -$15.26 | -$12.36 |
| Operating cash flow | -$5.9M | -$10.3M | -$11.0M | -$14.0M | -$15.7M | -$23.8M |
| Free cash flow | -$6.0M | -$10.3M | -$12.6M | -$15.7M | -$18.2M | -$27.7M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Line item | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$4.2M | -$5.0M | -$4.9M | -$5.0M | -$6.8M | -$7.8M | -$7.2M | -$5.7M |
| Net income | -$4.1M | -$5.0M | -$4.8M | -$4.9M | -$6.7M | -$7.8M | -$7.4M | -$6.4M |
| Diluted EPS | -$0.12 | -$0.14 | -$0.13 | -$14.87 | -$0.12 | -$0.14 | -$0.11 | -$11.99 |
| Operating cash flow | -$3.5M | -$3.8M | -$4.1M | -$4.3M | -$5.4M | -$5.4M | -$7.2M | -$5.8M |
| Free cash flow | -$4.4M | -$3.9M | -$4.6M | -$5.3M | -$6.3M | -$6.2M | -$8.4M | -$6.8M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Jul 1, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | FELSHER STEVEN G | Award | 25 | — | — | filing |
| 2026-06-30 | DIERSEN CARMEN L | Award | 110 | — | — | filing |
| 2026-06-30 | DeSisto Duane M | Award | 83 | — | — | filing |
| 2026-03-31 | FELSHER STEVEN G | Award | 25 | — | — | filing |
| 2026-03-31 | DeSisto Duane M | Award | 83 | — | — | filing |
| 2026-03-31 | DIERSEN CARMEN L | Award | 103 | — | — | filing |
| 2025-12-31 | DeSisto Duane M | Award | 2,500 | — | — | filing |
| 2025-12-31 | FELSHER STEVEN G | Award | 750 | — | — | filing |
| 2025-12-31 | DIERSEN CARMEN L | Award | 3,125 | — | — | filing |
| 2025-12-11 | FELSHER STEVEN G | Award | 60,000 | — | — | filing |
| 2025-12-11 | Sheibley Philip Brent | Award | 22,000 | — | — | filing |
| 2025-09-30 | FELSHER STEVEN G | Award | 750 | — | — | filing |
| 2025-09-30 | DeSisto Duane M | Award | 2,500 | — | — | filing |
| 2025-09-30 | DIERSEN CARMEN L | Award | 3,125 | — | — | filing |
| 2025-06-30 | DeSisto Duane M | Award | 2,500 | — | — | filing |
| 2025-06-30 | DIERSEN CARMEN L | Award | 3,125 | — | — | filing |
| 2025-06-30 | FELSHER STEVEN G | Award | 750 | — | — | filing |
Latest 17 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.